![]() |
|
|
Vol. 291, Issue 1, 285-291, October 1999
Lilly Research Laboratories, Neuroscience Discovery, Eli Lilly and
Company, Indianapolis, Indiana
Recent pharmacological studies have led to the hypothesis that
aminoglycoside-induced ototoxicity is an excitotoxic process mediated,
at least in part, by a polyamine-like modulation of N-methyl-D-aspartate (NMDA) receptors. To
explore this hypothesis, we compared the effects of several
aminoglycosides (neomycin B, kanamycin A, streptomycin, and
dihydrostreptomycin) with spermine on recombinant NMDA receptors of
defined composition expressed in Xenopus oocytes. Like
spermine, aminoglycosides potentiate agonist-induced responses in the
presence of both saturating glycine ("glycine-independent") and
subsaturating glycine ("glycine-dependent") concentrations on
NR1A/2B receptors. Likewise, aminoglycosides and spermine potentiated
the agonist responses under glycine-dependent conditions on NR1A/2A
receptors. Despite these similarities, several prominent differences
were observed between spermine and aminoglycosides as well as among
individual aminoglycosides. For example, neomycin B,
streptomycin, and kanamycin A, but neither spermine nor
dihydrostreptomycin, potentiated glycine-dependent responses on NR1A/2C
receptors. Differences between spermine and aminoglycosides also were
observed with respect to the voltage dependence of polyamine-like
actions. For example, under glycine-dependent conditions, potentiation at NR1A/2B receptors by spermine was voltage dependent, decreasing as
the holding potential was changed from
35 to
85 mV; in contrast, potentiation induced by aminoglycosides at NR1A/2B receptors was voltage independent. No direct relationships emerged between the effect
of an aminoglycoside at a specific NMDA receptor subtype and the
ototoxicity of these antibiotics.